Status:
UNKNOWN
Lung Cancer Screening by Low Dose CT Scan in a French Department (DEP KP80)
Lead Sponsor:
Centre Hospitalier d'Abbeville
Conditions:
Lung Cancer Screening
Eligibility:
All Genders
55-74 years
Phase:
NA
Brief Summary
Lung cancer is the leading cause of cancer death worldwide. The aims of this study were to assess the feasibility and effectiveness of a lung cancer screening pilot program with LD CT scan in a French...
Detailed Description
Scientific context : Lung cancer is the deadliest cancer in France and in the world. With around 39500 new cases in 2012 in France, lung cancer ranks fourth regarding cancer incidence for both women ...
Eligibility Criteria
Inclusion
- male or female
- smokers or former smoker,
- aged between 55 and 74
- tobacco exposure of more than 30 pack-years,
- active smokers or who quitted for less than 15 years,
- obvious symptoms.
Exclusion
- criteria:
- history of cancer within the last 5 years other than non melanoma skin cancer or carcinoma in situ,
- worsening of their health state with Eastern Cooperative Oncology Group performance status\>3,-
- heart or respiratory severe co-morbidity with contraindications to thoracoscopy
Key Trial Info
Start Date :
May 15 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2021
Estimated Enrollment :
1307 Patients enrolled
Trial Details
Trial ID
NCT03853967
Start Date
May 15 2016
End Date
May 15 2021
Last Update
February 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LELEU
Abbeville, Somme, France, 80100